Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela M Cirillo

Showing results (71-80 of 134) with videos related to

Pageof 14
Sort By:
ERJ Open Research|March 29, 2021
Chronic infection by nontypeable <i>Haemophilus influenzae</i> fuels airway inflammationFabio Saliu, Giulia Rizzo, Alessandra Bragonzi, et al.
African Journal of Laboratory Medicine|September 8, 2017
Mozambique's journey toward accreditation of the National Tuberculosis Reference LaboratorySofia O Viegas, Khalide Azam, Carla Madeira, et al.
The European Respiratory Journal|January 14, 2012
Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosisEnrico Tortoli, Cristina Russo, Claudio Piersimoni, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 23, 2009
Consensus not yet reached on key drugs for extensively drug-resistant tuberculosis treatmentGiovanni Battista Migliori, Giovanni Sotgiu, M D'Arcy Richardson, et al.
The Lancet Regional Health. Europe|December 1, 2025
Diagnostic algorithms for tuberculosis in Europe: insights from the European Reference Laboratory Network for Tuberculosis (ERLTB-Net)Francesca Saluzzo, Andrea Maurizio Cabibbe, Richard Anthony, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 28, 2019
Integrating Pharmacokinetics and Pharmacodynamics in Operational Research to End TuberculosisJan-Willem C Alffenaar, Tawanda Gumbo, Kelly E Dooley, et al.
International Journal of Systematic and Evolutionary Microbiology|November 8, 2015
Mycobacterium alsense sp. nov., a scotochromogenic slow grower isolated from clinical respiratory specimensEnrico Tortoli, Elvira Richter, Emanuele Borroni, et al.
BMC Microbiology|July 13, 2016
Genotypic and phenotypic relatedness of Pseudomonas aeruginosa isolates among the major cystic fibrosis patient cohort in ItalyCristina Cigana, Paola Melotti, Rossella Baldan, et al.
Plos One|April 25, 2022
Chromogranin A plasma levels predict mortality in COVID-19Rebecca De Lorenzo, Clara Sciorati, Giuseppe A Ramirez, et al.
Journal of Clinical Microbiology|December 10, 2020
Xpert MTB/XDR: a 10-Color Reflex Assay Suitable for Point-of-Care Settings To Detect Isoniazid, Fluoroquinolone, and Second-Line-Injectable-Drug Resistance Directly from Mycobacterium tuberculosis-Positive SputumYuan Cao, Heta Parmar, Rajiv L Gaur, et al.
Pageof 14

Showing results (71-80 of 134) with videos related to

Sort By:
Pageof 14
ERJ Open Research|March 29, 2021
Chronic infection by nontypeable <i>Haemophilus influenzae</i> fuels airway inflammationFabio Saliu, Giulia Rizzo, Alessandra Bragonzi, et al.
African Journal of Laboratory Medicine|September 8, 2017
Mozambique's journey toward accreditation of the National Tuberculosis Reference LaboratorySofia O Viegas, Khalide Azam, Carla Madeira, et al.
The European Respiratory Journal|January 14, 2012
Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosisEnrico Tortoli, Cristina Russo, Claudio Piersimoni, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 23, 2009
Consensus not yet reached on key drugs for extensively drug-resistant tuberculosis treatmentGiovanni Battista Migliori, Giovanni Sotgiu, M D'Arcy Richardson, et al.
The Lancet Regional Health. Europe|December 1, 2025
Diagnostic algorithms for tuberculosis in Europe: insights from the European Reference Laboratory Network for Tuberculosis (ERLTB-Net)Francesca Saluzzo, Andrea Maurizio Cabibbe, Richard Anthony, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 28, 2019
Integrating Pharmacokinetics and Pharmacodynamics in Operational Research to End TuberculosisJan-Willem C Alffenaar, Tawanda Gumbo, Kelly E Dooley, et al.
International Journal of Systematic and Evolutionary Microbiology|November 8, 2015
Mycobacterium alsense sp. nov., a scotochromogenic slow grower isolated from clinical respiratory specimensEnrico Tortoli, Elvira Richter, Emanuele Borroni, et al.
BMC Microbiology|July 13, 2016
Genotypic and phenotypic relatedness of Pseudomonas aeruginosa isolates among the major cystic fibrosis patient cohort in ItalyCristina Cigana, Paola Melotti, Rossella Baldan, et al.
Plos One|April 25, 2022
Chromogranin A plasma levels predict mortality in COVID-19Rebecca De Lorenzo, Clara Sciorati, Giuseppe A Ramirez, et al.
Journal of Clinical Microbiology|December 10, 2020
Xpert MTB/XDR: a 10-Color Reflex Assay Suitable for Point-of-Care Settings To Detect Isoniazid, Fluoroquinolone, and Second-Line-Injectable-Drug Resistance Directly from Mycobacterium tuberculosis-Positive SputumYuan Cao, Heta Parmar, Rajiv L Gaur, et al.
Pageof 14